Ignite Creation Date:
2024-05-06 @ 7:32 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02550535
Status:
COMPLETED
Last Update Posted:
2018-10-02
First Post:
2015-04-28
Brief Title:
A Phase III Study of Gene-modified WT1 TCR Therapy in MDS AML Patients
Sponsor:
Cell Medica Ltd
Organization:
Cell Medica Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-09
Start Date Type:
None
Primary Completion Date:
2018-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-05
Completion Date Type:
ACTUAL
First Submit Date:
2015-04-28
First Submit QC Date:
September 14 2015
Study First Post Date:
2015-09-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-10-01
Last Update Post Date:
2018-10-02
Last Update Post Date Type:
ACTUAL